Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07123272 · ClinicalTrials.gov registry record · NA

Usability of the MeTime MS App

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT07123272: Completed NA study, sponsored by University of Michigan.

NCT07123272 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07123272, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The Me Time MS Application was designed to enable self-administration of acupressure. Two forms of acupressure - either "relaxing" or "stimulating" protocols - are administered through the Me Time MS app. The goal of this study is to assess the usability of the Me Time MS app in a sample of 10 adults with multiple sclerosis (MS).

Primary Outcome

Qualitative descriptions of positive, negative, and neutral aspects of usability of the Me Time MS app, gathered through one-on-one, open-ended interviews after 6 weeks of access to the app. Results reflect the total number of comments across all participants that were provided for each category. Participants could submit multiple types of comments.

Interventions

  • BEHAVIORAL Self-guided smartphone application for relaxing acupressure
  • BEHAVIORAL Self-guided smartphone application for stimulating acupressure

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-03-17
Est. Completion 2025-05-16
Phase NA
University of Michigan

1,327 total trials

What the finished NCT07123272 record still lists

NCT07123272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Self-guided smartphone application for relaxing acupressure is the first listed.

NCT07123272 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07123272 about?

NCT07123272 is a clinical study titled "Usability of the MeTime MS App". The Me Time MS Application was designed to enable self-administration of acupressure. Two forms of acupressure - either "relaxing" or "stimulating" protocols - are administered through the Me Time MS app. The goal of this study is to assess the usability of the Me Time MS app in a sample of 10 adul...

What is the current status of trial NCT07123272?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2025-03-17. Estimated completion is 2025-05-16.

What interventions are being tested in trial NCT07123272?

The interventions under investigation include: Self-guided smartphone application for relaxing acupressure (BEHAVIORAL), Self-guided smartphone application for stimulating acupressure (BEHAVIORAL).

Who is sponsoring clinical trial NCT07123272?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07123272's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07123272, the US trial registry maintained by the National Library of Medicine. NCT07123272 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.